Discovery Research Domain Expert, IT Business Analyst at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Deep familiarity with early discovery Life Sciences domains (e.g., Molecular Invention, Early Biology, Preclinical Research, Biologics, Sequencing, Protein Engineering, Medicinal chemistry, DMPK)
Strong analytical skills to translate complex scientific needs into actionable IT requirements
Strong communication skills to act as a link between scientific teams and IT/engineering teams
Passionate, inquisitive, and energetic mindset
Hands-on business analyst experience in defining technical specifications, user stories, and requirements
Ability to work directly with predictive modelers, lab scientists (Biologics & Large Molecule, Chemists, In Vivo Researchers), data engineers, Product Managers, Sr. Business Analysts, Data Scientists, and Research stakeholders

Responsibilities

Partner with Research stakeholders (Biologics, Discovery Biotherapeutics, Next Gen Sequencing, Thematic Research Centers, Chemistry, DMPK, etc.) to understand data workflows and define business requirements
Translate scientific needs into technical specifications, user stories, and actionable requirements for IT and engineering teams
Shape and prioritize demand by mapping end-to-end processes, identifying root causes of friction, and focusing on business value creation
Serve as the “voice of the scientist,” ensuring product teams deliver solutions that reflect real-world context and meet evolving needs
Collaborate with Data Engineers to collect, test, validate, and continuously enhance data products for usability and quality
Develop and maintain field-level metadata, business glossaries, and contribute to FAIR-aligned practices (Findable, Accessible, Interoperable, Reusable)
Support scientific alignment of identifiers, terminology, and definitions across MI data sources to enhance downstream integration and analytics
Lead stakeholder assessments to anticipate friction, clarify expectations, and build sustained trust in data product capabilities

Skills

Drug Discovery

Life Sciences

Business Analysis

Data Solutions

Molecular Biology

Biologics

Large Molecule

Chemistry

In Vivo Research

Predictive Modeling

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free